Ascertain — a healthcare AI company creation platform formed last year by Northwell Health and Aegis Ventures — has launched its first startup. New York-based Optain, which has gained an initial seed investment of $12 million, is an AI company meant to enable earlier disease detection and prevention through retinal imaging.
Bethesda, Maryland-based RightEye has received a 510(k) clearance for its EyeQ eye-tracking platform using competitor SyncThink's technology as a predicate device.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
If Google is able to overcome the many hurdles to bringing this device to market, it could revolutionize the eye care industry. “What’s in their patent is the Holy Grail for patients over 40 years old," said Dr. Jeffrey Sonsino, an optometrist in Nashville, Tennessee.
In the highly fragmented EMR market, how do you build an efficient product that doctors actually want to use? Maybe hire physicians in your target markets and join up with an entrepreneur who co-founded Blackboard, the popular virtual education company with more than 9,300 international clients and a $1.6 billion buyout? That was Modernizing Medicine’s […]
EyeNetra is developing a device that attaches to a mobile phone and can detect myopia, astigmatism and other eye conditions.
A comprehensive laser eye surgery system that would automate manual incisions and eliminate the need for ultrasound power in cataract refractory procedures is preparing for commercial launch in the U.S., Europe and other international markets. LensAR Inc.’s laser system for cataract eye surgery combines advanced measurement and scanning technology with femtosecond laser technology, which uses […]
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
A Michigan company developing a treatment to help restore vision in patients with retinal degeneration hopes to have its lead candidate in clinical trials in 2012. RetroSense Therapeutics, an Ann Arbor startup company, is targeting patients with blindness from retinal pigmentosa (RP) and advanced dry age-related macular degeneration (dry-AMD) for its new therapy derived from […]
A medical device dry-eye treatment that wants to replace eye drops has received U.S. Food and Drug Administration approval. North Carolina’s TearScience has won FDA approval for its LipiFlow Thermal Pulsation device, which can eliminate gland blockages that in many cases keep the eye from being properly lubricated. A limited number of the LipiFlow medical […]
Restoring vision to the blind is the sort of feat reserved for ancient religious texts and modern science fiction novels. But Retina Implant AG did just that with an implant inserted into the eye to treat back-of-the-eye disorders. A first clinical trial showed the device can enable people suffering from a certain type of macular degeneration to see.
It’s not exactly bringing sight to the blind, but Wicab Inc.‘s technology has a similar effect. The company’s BrainPort device works by translating images from a digital camera mounted on a user’s sunglasses to electric pulses on a device that’s worn on the tongue, allowing a blind person to learn how to interpret those pulses […]
The progress in artificial intelligence (AI) is reshaping patient care, across various dimensions, from facilitating faster discharge to curating treatment plans and suggesting lifestyle changes.
The Cleveland Eye Clinic is using a revolutionary new computer device that helps cataract patients avoid a second surgery to fix a lens. Lenny Rock was a competitive archer until he developed a cataract. “My vision was going. I couldn’t see. That’s the reason I slowed down on competition. It was like looking through a […]
The company moved into the optical device market in February when it closed on a $2.8 billion deal to acquire Advanced Medical Optics, which made devices for cataract and LASIK surgery, as well as contact lens and eye solutions. Visiogen, meanwhile, has developed an intraocular lens that's implanted in a patient's eye after the original is removed due to cataracts.
The five-year study will look at Alzheimer's patients who also have cataracts and document how better vision improves their quality of life. People with dementia lose their ability to see objects that are of lower contrasts to the areas around them.